about
Vitamin A and Alzheimer's diseaseA Role for the Brain RAS in Alzheimer's and Parkinson's DiseasesMemoquin: a multi-target-directed ligand as an innovative therapeutic opportunity for Alzheimer's diseaseNeuroprotective and neurotoxic properties of glial cells in the pathogenesis of Alzheimer's diseaseScutellarin protects against Aβ-induced learning and memory deficits in rats: involvement of nicotinic acetylcholine receptors and cholinesterase.Reversed-phase liquid chromatographic determination of tramiprosate in rat plasma using evaporative light scattering detector.Phenelfamycins G and H, new elfamycin-type antibiotics produced by Streptomyces albospinus Acta 3619.Drug development for Alzheimer's disease: where are we now and where are we headed?Targeting NOX enzymes in the central nervous system: therapeutic opportunities.Structure-based search for new inhibitors of cholinesterases.Advances in tau-based drug discovery.Neuronal death in Alzheimer's disease and therapeutic opportunities.Molecular Docking Study on Galantamine Derivatives as Cholinesterase Inhibitors.Impact of amyloid imaging on drug development in Alzheimer's disease.Inhibition of acetylcholinesterase by two genistein derivatives: kinetic analysis, molecular docking and molecular dynamics simulationPresent and prospective clinical therapeutic regimens for Alzheimer's disease.Imaging hydrogen peroxide in Alzheimer's disease via cascade signal amplificationEarly administration of RS 67333, a specific 5-HT4 receptor agonist, prevents amyloidogenesis and behavioral deficits in the 5XFAD mouse model of Alzheimer's disease.Challenges and opportunities in CNS delivery of therapeutics for neurodegenerative diseases.Does Alzheimer's disease begin in the brainstem?Emerging cognitive enhancing drugs.The role of tau in Alzheimer's disease and related disorders.The development of new therapeutics for Alzheimer's disease.Finding order within disorder: elucidating the structure of proteins associated with neurodegenerative disease.Solanezumab for Alzheimer's disease.The retina as a window to the brain-from eye research to CNS disorders.Huprines for Alzheimer's disease drug development.RAGE regulation and signaling in inflammation and beyond.Multi-target design strategies in the context of Alzheimer's disease: acetylcholinesterase inhibition and NMDA receptor antagonism as the driving forces.Multitarget strategies in Alzheimer's disease: benefits and challenges on the road to therapeutics.Kinetics and Molecular Docking Study of an Anti-diabetic Drug Glimepiride as Acetylcholinesterase Inhibitor: Implication for Alzheimer's Disease-Diabetes Dual Therapy.Pretreatment of SH-SY5Y cells with dicaffeoylquinic acids attenuates the reduced expression of nicotinic receptors, elevated level of oxidative stress and enhanced apoptosis caused by β-amyloid peptide.Mild cognitive impairment: searching for the prodrome of Alzheimer's disease.Aβ oligomer toxicity inhibitor protects memory in models of synaptic toxicity.Amyloid peptides incorporating a core sequence from the amyloid beta peptide and gamma amino acids: relating bioactivity to self-assembly.Synaptic failure and adenosine triphosphate imbalance induced by amyloid-β aggregates are prevented by blueberry-enriched polyphenols extract.Design and Synthesis of Hydroxyethylene-Based BACE-1 Inhibitors Incorporating Extended P1 Substituents.Molecular Modeling on Berberine Derivatives toward BuChE: An Integrated Study with Quantitative Structure-Activity Relationships Models, Molecular Docking, and Molecular Dynamics Simulations.Nature Versus Nurture: Does Proteostasis Imbalance Underlie the Genetic, Environmental, and Age-Related Risk Factors for Alzheimer's Disease?L-arginine and Alzheimer's disease.
P2860
Q22242414-F44526BC-2651-494C-91F3-ACE91DB713C1Q26861984-40FFFADE-D2AE-460D-BB28-ED3F20DC1505Q28820783-3ECFC1A2-2599-4B0F-97B5-9821560D1FF4Q30054419-E1B49DBC-8B01-4DB5-BF01-E6527F974287Q33566782-A9D5FAD2-E4E1-4BB7-B067-BBCC07BE3BB8Q33770805-E04FDD55-80C7-401A-A514-B0A829B8888FQ34162078-93234FBA-6ACB-4C5D-9673-A4EC9B9D01B4Q34166256-76B76B12-90F7-48C9-B8FD-525A1BAEC0DFQ34285497-AE8F2DE9-8334-43CA-813D-B39C6513AF8AQ34616235-61D20EE7-BBAE-4680-8DF5-E6B85CB8ADF9Q35321539-C040E0EE-1EA6-4644-8AC6-4897805F1CA7Q35889067-1FC3ED33-5319-4307-BE40-E059C205273EQ36094892-F9BE91A1-F7E3-4A7C-8148-C3BA3C31C98BQ36144632-C25D9104-8FC5-4E8A-9E39-5D02040EF06DQ36237626-9B628C46-8FC8-4C46-A416-55819E940F6FQ36876447-04AEAE39-1118-44A5-8748-1E57847D02C2Q37352823-81DAE983-B503-4491-99CD-05E53329D72AQ37412086-DF201151-0FA3-4A82-896A-A01DACD8744CQ37416147-23279EFA-B9C1-4C33-963C-A649BB2A6CAFQ37456054-1128FE3D-1C02-474B-AD68-7B583097A945Q37601479-99FB12EF-97E7-4DC3-8095-94436F4C6D48Q37765632-892D282D-C7DC-4C2A-A72C-503456108ED5Q37784685-848E3C1F-54CE-4772-9BBE-21D63282F593Q37855889-83754403-0944-4F3D-8F4F-E2D2E289B909Q37866811-E2B3F37C-2E85-4596-955D-AE1273735662Q38061012-15CFAB6C-B028-4DDF-83AD-A310DAD7C41CQ38088283-DAE3A94D-0CAF-4789-8D4F-A0A4745D7826Q38094691-6757E116-200C-42F6-9E6B-1B8E27205334Q38184970-A0545FC4-0EC8-4D47-9EE6-5335AA26DE21Q38881147-74B96AB8-1386-4638-AEDE-9070F7287C13Q38906901-D704E48D-CE17-46B9-87EA-822A45E8A1E6Q39062859-7D351D99-8518-4F60-8584-ECD8E698BF3DQ39250175-9F9D6634-6530-4037-9903-7C9487312F3CQ39293031-C31D0962-3133-4A7A-A6D8-B8A9204E19FDQ39449996-19C4CF5D-7CFD-4B41-A8CD-31153E509AB0Q39529340-B7C8EFAD-ED1A-41A5-BFCD-4D02758D05B8Q39622297-87B5A032-F175-4DA4-A2D1-066A748127EEQ40230831-B1990E65-4F4F-496A-B047-2E634C85C737Q41665563-5DBC2593-C480-4C50-9171-C6E01036D798Q41767433-B43DA8F5-5249-454E-95B8-CE579FC0834D
P2860
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Therapies for Alzheimer's disease.
@en
Therapies for Alzheimer's disease.
@nl
type
label
Therapies for Alzheimer's disease.
@en
Therapies for Alzheimer's disease.
@nl
prefLabel
Therapies for Alzheimer's disease.
@en
Therapies for Alzheimer's disease.
@nl
P356
P1476
Therapies for Alzheimer's disease.
@en
P2093
Irena Melnikova
P2888
P304
P356
10.1038/NRD2314
P577
2007-05-01T00:00:00Z
P6179
1020581045